Related Experiment Videos
Extrapyramidal symptoms with selective serotonin reuptake inhibitors
1Peter Hodgkinson Centre, County Hospital, Lincoln.
The British Journal of Psychiatry : the Journal of Mental Science
|December 1, 1994
Summary
Selective serotonin reuptake inhibitors (SSRIs) may cause extrapyramidal symptoms in some patients. Research suggests a link between the serotonergic and dopaminergic systems may be responsible.
Area of Science:
- Neuroscience
- Pharmacology
- Clinical Medicine
Background:
- Case reports indicate selective serotonin reuptake inhibitors (SSRIs) may induce extrapyramidal symptoms.
- Extrapyramidal symptoms are a known potential side effect of certain medications.
Purpose of the Study:
- To investigate the association between SSRIs and extrapyramidal symptoms.
- To explore the potential mechanisms underlying SSRI-induced extrapyramidal symptoms.
Main Methods:
- Conducted computerized literature searches for reports on SSRIs and extrapyramidal symptoms.
- Performed manual searches to identify studies detailing the mechanisms of these symptoms.
Main Results:
- A limited number of reports were found implicating SSRIs in extrapyramidal symptoms.
- Evidence suggests a connection between SSRI use and the occurrence of these symptoms in some individuals.
Conclusions:
- Preclinical and clinical evidence points to the interaction between serotonergic and dopaminergic neurotransmitter systems.
- This neurochemical interaction is proposed as a potential mechanism for SSRI-induced extrapyramidal symptoms.